Skip to main content
Fig. 4 | BMC Immunology

Fig. 4

From: Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary Sjögren’s syndrome

Fig. 4

Artemisinin treatment reduced infammatory infltration and improved saliva fow rate in NOD/Ltj mice. A The saliva flow rate of each group. B The number of lymphocytic infiltration foci in each group. C The pathological score of each group. D HE staining of submandibular gland of mice in each group. a: normal group, b: NOD/Ltj model group, c: artemisinin group, d: HCQ group (*P < 0.05 compared with the normal group; #P < 0.05 compared with the model group; ΔP < 0.05 compared with the HCQ group)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us